KOSPI · Healthcare · ₩149B
₩8,410+0.12%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 4.5% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“기존 의약품 기반 위에 생산 확대를 준비하는 분기예요.”
In the company's words · 2026 2분기 filing